Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for Knee Replacement Surgery
Perform Another (Advanced) Search
9 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. Study Posting (1570) Trial #156571, Knee Replacement, Morristown, NJ ...1570) Trial #156571, Knee Replacement, Morristown, NJ Trial Information Study of MK0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain A Phase III Randomized, Double-Blind, Placebo and Active Comparator-Controlled, Multiple Dose ...View Page
2. CenterWatch: New Medical Therapies in Disease Category (316), Knee Replacement ...a phase III trial of Adlea for the reduction of post-surgical pain following total knee replacement surgery. This multi-center, randomized, double-blind, placebo-controlled phase II study, dubbed ACTIVE-2 ...View Page
3. CenterWatch: Clinical Trials in Category (316) Knee Replacement ...State • New Jersey New Jersey Morristown : Atlantic Health System Study of MK0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed ...View Page
4. Newly Approved Drug Therapies (748) Arixtra, Organon, Sanofi-Synthelabo, ...preventative treatment for deep vein thrombosis (DVT) in adults undergoing hip fracture, hip replacement, or knee replacement surgery. It is adminstered through a single dose, prefilled syringe, affixed with an automatic needle ...View Page
5. CenterWatch: New Medical Therapies in Disease Category (565), Post-Surgical Pain ...a phase III trial of Adlea for the reduction of post-surgical pain following total knee replacement surgery. This multi-center, randomized, double-blind, placebo-controlled phase II study, dubbed ACTIVE-2 ...View Page
6. CenterWatch: New Medical Therapies in Disease Category (147), Thrombosis ...prevention of venous thromboembolism (VTE). This study, dubbed ADVANCE-1, enrolled 3,000 subjects undergoing knee replacement surgery. The subjects received apixaban, 2.5 mg given twice daily, or enoxaparin, 30 mg ...View Page
7. Newly Approved Drug Therapies (275) Normiflo, Wyeth, ...study, dosing regimens of Normiflo were compared to warfarin for preventing DVT in patients electing knee replacement surgery, a procedure that puts patients at high risk of developing the condition. Normiflo was ...View Page
8. CenterWatch Clinical Industry Provider Profile(4489), Institute of Human Health Research, Stratford, PE, Canada ...Dysfunction Post-Operative Nausea and Vomiting Ulcerative Colitis Musculoskeletal Prevention of Deep Vein Thrombosis in knee replacement surgery Nephrology/Urology Benign Prostatic Hypertrophy Overactive Bladder Neurology Alzheimer's Disease Chronic Back Pain ...View Page
9. CenterWatch Clinical Research Profile (1570) Trial #819, Atlantic Health System, Morristown, NJ ...Solution in Patients With Cystic Fibrosis (CF) Lung Disease • Study of MK0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain • Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.